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SUMMARY
Background: Good glycoregulation at patients with diabetes mellitus 
is essential for prevention of many complications, including those in 
oral cavity. Results of numerous studies indicate that xerostomia and 
neurosensory oral disorders are present in type 2 diabetics. A review of the 
literature shows contradictory results about prevalence of oral mucosal 
lesions in diabetics. The aim of this study was to evaluate the presence of 
xerostomia, neurosensory disorders and mucosal lesions in oral cavity of 
type 2 diabetics. Material and Methods: This study involved 90 adults, 60 
with type 2 diabetes and 30 healthy subjects, aged 45-65 years. With regard 
to value of HbA1c level diabetics were divided into two groups: 30 subjects 
with satisfactory glycoregulation (HbA1c<9%) and 30 subjects with poor 
glycoregulation (HbA1c≥9%). All patients recruited into the study completed 
a questionnaire that included their demographic, medical and oral health 
data. Clinical examination of the oral mucosa was performed by a single 
examiner. Results: In relation to the presence of xerostomia and dysgeusia 
between satisfactory controlled diabetics and healthy subjects a significant 
difference was observed (p<0.05). Compared with healthy subjects, poor 
controlled diabetics had significantly higher presence of xerostomia 
(p<0.001) and neurosensory disoders (p<0.05). A higher prevalence of 
oral mucosal lesions was found in poor controlled diabetics, but significant 
difference between groups was not observed (p>0.05). A significant positive 
correlation was revealed between smoking and glossodynia as well as 
smoking and glossopyrosis (p>0.05). Conclusion: Glycemic control level 
seems to influence the susceptibility of type 2 diabetics to xerostomia and 
neurosensory disorders. Less clear is whether diabetes are corellated to oral 
mucosal lesions.
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Introduction
Diabetes Mellitus (DM) is a metabolic disorder 
characterized by chronic hyperglycemia and disturbances 
of carbohydrate, fat and protein metabolism1. Chronic 
hyperglycemia leads to many complications, including 
those in oral cavity, therefore metabolic control is very 
important. Possible mechanisms that may be associated 
with some oral manifestations of diabetes are impaired 
chemotaxis as well as adherence and phagocytosis of 
neutrophil2, increased collagenase activity together with a 
decrease in collagen synthesis3, diabetic microangiopathy 
and neuropathy4.
Dry mouth or xerostomia is often present in 
patients with diabetes. It is believed that a decrease in 
saliva secretion by 50% below the normal range leads 
to xerostomia5. Shepard was the first one who described 
xerostomia in 1942 as a feature of uncontrolled diabetes6. 
It seems that oral dryness in type 2 DM is particularly 
influenced by xerogenic drugs and autonomic neuropathy. 
Moreover, neurosensory disorders such as burning mouth 
sensation and taste alteration are present in diabetics7. 
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All recruited patients completed a questionnaire 
that included their demographic and tobacco history 
data as well as oral health data which included a list of 
questions about their subjective oral symptoms. Some of 
the questions regarding dry mouth were patterned after 
those of Zielinski et al.14: Does your mouth frequently 
feel dry? Does your mouth feel dry when you are eating 
a meal? Do you have difficulties swallowing dry foods? 
Does oral dryness wakes you from sleep at night? 
A response of “yes” to two or more questions was 
considered positive for xerostomia. Also, the questions of 
dry mouth-associated complaints were included15: Do you 
have a painful tongue sensation? Do you have a burning 
tongue sensation? Do you have a taste alteration? Painful 
tongue sensation and burning tongue sensation are also 
referred as glossodynia and glossopyrosis respectively. All 
symptoms was evaluated with binary response options.
In relation to diabetes mellitus, data included a 
level of metabolic control and duration of diabetes 
according to their medical records. Clinical examination 
was performed by a single examiner on Dental Clinic, 
Faculty of Medicine Foca, University of East Sarajevo, 
Republic of Srpska, Bosnia and Herzegovina according 
to WHO criteria16 and included inspection of the soft 
tissues. Two mouth mirrors were used as well as digital 
palpation for the examination of particular lesions. The 
following oral mucosal changes were recorded: angular 
cheillitis (fissures or inflammation at lip corners), possible 
lichenoid lesion (white areas of the mucosa that do not 
wipe off, lacey or patch-like white pattern over reddened 
surface) and aphtae (ulcer(s) on oral mucosa except 
gingiva and hard palate).
Statistical analyses
All statistical analyses were performed with SPSS 
version 19.0 for Windows. Results were expressed as 
mean values ± standard deviation (SD) for numerical 
variables and as percentage for attributive variables. The 
differences between the groups were assessed by One 
Way ANOVA, T test and chi-square test. Spearman’s 
correlation coefficient were obtained in order to assess the 
relationship between smoking and oral complaints as well 
as smoking and mucosal lesions. The value of p<0.05 was 
considered statistically significant.
Results
Table 1. shows sociodemographic characteristics of 
all respondents. Statistically significant difference was 
observed for smoking habits and average of age between 
the groups, while significant difference was not observed 
for gender. 
In patients with diabetes, a pain or burning is usually 
expressed on the tongue (glossodynia and glossopyrosis), 
but other parts of the mouth may be affected as well. The 
underlying cause of these sensation in diabetics could be 
diabetic neuropathy. 
Many factors might have been implicated in altered 
taste sensation in the oral cavity. One study reports that 
one-third of patients with diabetes have dysgeusia8, but 
not all studies describe these changes and their prevalence 
is unknown. Although the physiology of dysgeusia is not 
completely understood, relationship between dysgeusia 
and diabetic neuropathy has been described in earlier 
studies9. Taste alteration is reported to be more prevalent 
especially in poor controlled diabetics10.
A number of oral mucosal lesions, including lichen 
planus, recurrent aphthous stomatitis11 and angular 
cheilitis12 have been reported in diabetic patients, but 
there is no consensus whether oral mucosal lesions are 
more prevalent in diabetics than in healthy subjects. The 
relationship between diabetes and oral mucosal lesions is 
still unclear. 
The aim of this study was to evaluate the presence of 
xerostomia, neurosensory disorders and mucosal lesions 
in oral cavity of type 2 diabetics.
Material and Methods
Study design and participants 
The present study was approved by the institutional 
committee of ethics (No. 01-8/140 issued on 24th of 
December 2009) and was conducted in accordance with 
the Helsinki Declaration of 1975, as revised 1983.
This study was designed as a cross-sectional study. 
A total of 90 adults, aged 45-65 years, participated in 
the study. The study group included 30 satisfactory 
controlled diabetes mellitus type 2 patients (HbA1c<9%) 
and 30 poor controlled diabetes mellitus type 2 patients 
(HbA1c≥9%), who were recruited from the Department 
of Endocrinology University hospital Foca, Republic 
of Srpska, Bosnia and Herzegovina. The 9% cut-off 
point has been suggested to represent an indicator 
for ineffective blood glucose management in type 2 
diabetes13. The mean duration of diabetes was 8.57±7.44 
years in patients with satisfactory glycoregulation 
and 9.18±6.97 in patients with poor glycoregulation. 
The control group consisted of 30 healthy individuals 
who visited Dental Clinic, Faculty of medicine Foca, 
University East Sarajevo, for regular check up. 
After the study was explained to the patients, written 
informed consent was obtained from all. 
The presence of other systemic disorder or severe 
mental illness, pregnancy, signs or symptoms of AIDS and 
antibiotic administration during the last 6 months were 
exclusion criteria in this study.
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Table 1. Sociodemographic characteristics of the sample
Variables All patients SCD PCD HS p
Age
( ±SD)
57.58±7.19 59.50±6.64 60.73±5.89 52.50±6.27 p*<0.05
Gender
(%)
Male 57.8 53.3 43.3 30.0
p**>0.05
Female 42.2 46.7 56.7 70.0
Smoking
(%)
Yes 38.9 33.3 46.7 36.7
p**<0.05
No 61.1 66.7 53.3 63.3
*ANOVA; * * χ2 test;  SCD-satisfactory controlled diabetics; PCD-poor controlled diabetics; HS-healthy subjects;
Table 2. shows the presence of xerostomia and 
neurosensory disorders in all patients. A statistically 
significant difference was observed between healthy 
subjects and diabetics with satisfactory glycoregulation, 
except for glossodynia and glossopyrosis. Compared with 
healthy subjects, poor controlled diabetics had significantly 
higher presence of xerostomia and neurosensory disorders. 
Table 2. Presence of xerostomia and neurosensory disorders in 
patients 
Variables (%) SCD PCD HS p*
Xerostomia
yes 53.3 83.3 20.0 SCD:HS<0.05
no 46.7 16.7 80.0 PCD:HS<0.001
Glossodynia
yes 13.3 26.7 3.3 SCD:HS>0.05
no 86.7 73.3 96.7 PCD:HS<0.05
Glossopyrosis
yes 13.3 26.7 3.3 SCD:HS>0.05
no 86.7 73.3 96.7 PCD:HS<0.05
Dysgeusia
yes 30.0 30.0 3.3 SCD:HS<0.05
no 70.0 70.0 96.7 PCD:HS<0.05
*χ2 test; SCD- satisfactory controlled diabetics; PCD-poor 
controlled diabetics; HS-healthy subjects;
The frequency of oral mucosal lesions in all 
respondents are presented in Table 3. Poor controlled 
diabetics had higher prevalence of oral mucosal lesions, 
than satisfactory controlled diabetics and healthy subjects, 
but statistically significant difference between the groups 
was not observed.
Table 3. Presence of oral mucosal lesions in patients 
Oral mucosal lesions
LP
(%)
RAS
(%)
AH
(%) p*
SCD 6.7 10.0 3.3
p>0.05PCD 10.0 10.0 6.7
HS 6.7 6.7 0.0
*χ2 test; LP-Lichen planus;RAS-recurrent aphtosus 
stomatitis;AH-angular cheilitis;
SCD- satisfactory controlled diabetics; PCD-poor controlled 
diabetics; HS-healthy subjects
Spearman’s correlation revealed a statistically 
significant correlation between smoking and glossodynia 
as well as smoking and glossopyrosis. For all other 
variables investigated (xerostomia, dysgeusia and mucosal 
lesions), we observed a positive but nonsignificant 
correlation between them and smoking (Table 4).
Table 4. Correlation between smoking and oral complaints as 
well as smoking and mucosal lesions 
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Smoking 0.079 0.256* 0.256* 0.090 0.042
 * p< 0.05; Spearman’s correlation coefficient
Discussion
Xerostomia is one of DM oral manifestations. 
Its presence can lead to numerous clinical and social 
problems and certainly may have a negative impact on 
patients’ quality of life. It is a result of reduction in saliva 
secretion, although it may occur in presence of a normal 
saliva flow rate as well17. In fact, autonomic neuropathies 
diminish the ability to respond to a salivary stimulus, but 
also microvascular changes may compromise the ability 
of salivary glands to respond to neural and hormonal 
stimulation in poor controlled diabetics18. Xerostomia 
may also be caused by administration of drugs. Drug-
induced xerostomia occurs most often as a result of 
reversible action of drugs on the neural mechanism 
responsible for salivation. Medications with anticholinergic 
activity, such as tricyclic antidepressants, anxiolytics and 
antihypertensives exhibit the greatest xerogenic potential19. 
Presence of xerostomia can contribute to many clinical 
problems such as difficulty in eating, swallowing and 
speaking. Some patients may have a halitosis, burning 
sensation and altered taste perception15.
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Studies have reported decreased phagocytic activity 
of neutrophils in diabetics. Also, collagen synthesis is 
under the influence of the glucose level which may lead 
to increased susceptibility to infections and impaired 
wound healing. Previous studies reported contradictory 
results about oral mucosal lesions prevalence in patients 
with diabetes mellitus type 2. In our oral mucosal lesions 
frequency analysis, diabetics had a greater presence 
of oral mucosal lesions, but there was no significant 
difference between the groups. Other studies have 
also found that patents with type 2 DM did not have 
an increased presence of oral lesions28. Some studies 
however, demonstrated significantly higher prevalence 
of mucosal changes in diabetics. Bastos et al. observed 
146 patients suffering from type 2 diabetes and 111 
healthy subjects29. In their study, lichen planus was 
diagnosed in 6.1% of diabetics, while in the group of 
healthy individuals there were no respondents with this 
oral lesion. More over, angular cheillitis was present in 
15.0% diabetics and 9.0% healthy subjects. However, the 
review of literature show conflicting results regarding 
the presence of oral mucosal lesions in type 2 diabetics. 
Thus, for example, the prevalence of lichen planus varies 
from 1.6% to as much as 85%30. Some authors believe 
that the higher prevalence of oral lesions is associated 
with poor metabolic control of the disease31,32. Others 
believe that the key is in the immune response such as 
lower chemotaxis and phagocytosis and the involvement 
of microcirculation with the reduction of blood supply, 
which contributes to diabetics becoming more prone to 
infections and alterations in the oral cavity29,33.
Conclusions
The results of this study indicate that patients with 
diabetes mellitus type 2 are more susceptible to oral 
changes, especially poor controlled ones. Glycemic 
control level seems to influence the susceptibility of type 
2 diabetics to xerostomia and neurosensory disorders. 
Less clear is whether diabetes is correlated to oral 
mucosal lesions. However, it was not possible to observe 
a clear relationship between the frequency of oral mucosal 
lesions related to diabetes mellitus type 2, probably due to 
small sample size. 
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